Product image of Mometasone Aristo (Mometasone Furoate Ph. Eur.) supplied by GNH India

Mometasone Aristo

Active Ingredient:
Mometasone Furoate Ph. Eur.
Origin:
EU

Mometasone Aristo (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometasone Aristo, is a potent glucocorticoid corticosteroid presented as a nasal spray for intranasal administration. It reduces nasal inflammation and congestion associated with allergic rhinitis, including both seasonal and perennial types, in adults and children.

GNH India supplies Mometasone Aristo as a licensed, GMP‑compliant pharmaceutical product, providing reliable international distribution to hospitals, pharmacies and clinics worldwide, with full adherence to Good Distribution Practice and regulatory standards, and ensuring product integrity throughout the supply chain.

Manufacturer / TM Owner

Aristo Pharma Gmbh (Art 57)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages, primarily allergic rhinitis.

  • Allergic rhinitis: relief of nasal congestion, itching, sneezing and rhinorrhea.
  • Seasonal allergic rhinitis: control of symptoms during pollen or mold seasons.
  • Perennial allergic rhinitis: reduction of year‑round nasal inflammation and mucus production.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors in nasal mucosal cells, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses pro‑inflammatory cytokine production, inhibits leukocyte infiltration, and reduces vascular permeability, leading to decreased nasal edema, mucus secretion, and overall inflammatory response.

Side Effects

Adverse reactions are generally localized to the nasal cavity, but systemic effects can occur with excessive use.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Headache.
  • Epistaxis (nosebleeds).
  • Throat irritation or dryness.
  • Cough.
  • Altered taste or bitter taste.

Serious or Rare Side Effects

  • Nasal septal perforation.
  • Severe allergic reaction (anaphylaxis).
  • Vision changes such as cataracts or glaucoma.
  • Adrenal suppression with prolonged high‑dose use.
  • Opportunistic fungal infection of the nasal passages.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess for active nasal infections: avoid use until infection resolved.
  • Hypersensitivity: discontinue if patient shows allergy to mometasone or other steroids.
  • Use the lowest effective dose to minimize systemic exposure.
  • Monitor for signs of systemic glucocorticoid effects, especially with long‑term use.
  • Caution in patients with uncontrolled diabetes or hypertension.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Mometasone nasal spray may interact with other medications; awareness of interaction severity helps guide clinical decisions.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic corticosteroid exposure.
  • Concurrent systemic corticosteroids can amplify adrenal suppression risk.
  • Live vaccines may have reduced efficacy when used with intranasal steroids.

Moderate Interactions (Monitor Closely)

  • Other intranasal decongestants may increase local irritation.
  • Oral antihistamines may add to sedation if they have sedating properties.
  • Immunosuppressants may raise infection susceptibility.
  • Antifungal nasal preparations may alter local flora.
  • Nasal antihistamine sprays may affect absorption of mometasone.

Frequently Asked Questions

Mometasone Aristo is indicated for the management of allergic rhinitis, including both seasonal and perennial forms. It helps relieve nasal congestion, itching, sneezing, and runny nose by reducing inflammation in the nasal passages.

Mometasone furoate acts as an agonist at glucocorticoid receptors in nasal mucosal cells. By binding these receptors, it modulates gene expression to suppress inflammatory cytokines, decrease leukocyte migration, and reduce vascular permeability, which together diminish nasal swelling and mucus production.

The specific dosing regimen for Mometasone Aristo is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing it to pregnant or nursing women, and use the lowest effective dose if deemed necessary.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mometasone furoate is a high‑potency intranasal glucocorticoid with a favorable safety profile when used at recommended doses. Compared with lower‑potency options such as fluticasone propionate, mometasone may achieve symptom control with fewer daily sprays, but individual response can vary.

Store the nasal spray at room temperature, below 25 °C (77 °F). Keep the container tightly closed, protect it from moisture and direct sunlight, and do not freeze the product. Follow any additional instructions on the label.

Mometasone Aristo is administered as a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of puffs while breathing in gently. The process is repeated in the other nostril if directed.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, adrenal suppression with prolonged high‑dose use, and opportunistic fungal infections of the nasal mucosa. Patients should seek medical attention if they experience unusual bleeding, persistent pain, or systemic symptoms.

Mometasone Aristo should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal infections or recent nasal surgery unless directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate Ph. Eur.

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT